Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis

Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis

Ping Dai, Jing Li, Xiao-Ping Ma, Jian Huang, Juan-Juan Meng, Ping Gong Department of Oncology, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, Xinjiang, People’s Republic of China Background: The study of cyclooxygenase-2 (COX-2) inhibitors is now mired in...

Full description

Bibliographic Details
Main Authors: Dai P, Li J, Ma XP, Huang J, Meng JJ, Gong P
Format: Article
Language:English
Published: Dove Medical Press 2018-02-01
Series:OncoTargets and Therapy
Subjects:
Cyclooxygenase-2 inhibitors
Non-small cell lung cancer
Chemotherapy
Overall survival
Meta-analysis
Online Access:https://www.dovepress.com/efficacy-and-safety-of-cox-2-inhibitors-for-advanced-non-small-cell-lu-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/efficacy-and-safety-of-cox-2-inhibitors-for-advanced-non-small-cell-lu-peer-reviewed-article-OTT

Similar Items